ACE inhibitor reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction

Although treatment with angiotensin-converting enzyme (ACE) inhibitors is known to improve outcome for patients with left ventricular dysfunction, (1,2) their use in the community has been suboptimal.(3) Even when ACE inhibitors are prescribed, the dose used is usually below what has been shown to be effective in randomized clinical trials.(4) The goal of this study was to determine if the addition of a reminder to the echocardiography report for patients with a reduced ejection fraction could increase the use of moderate or greater doses of ACE inhibitors or alternative appropriate treatment (eg, angiotensin receptor blockers).